Cover Image
Market Research Report

Global Infectious Diseases Market Size, Status and Forecast 2019-2025

Published by QYResearch Product code 797928
Published Content info 106 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Infectious Diseases Market Size, Status and Forecast 2019-2025
Published: July 9, 2019 Content info: 106 Pages
Description

When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antiprotozoal and antihelminthic) agents.

Depending on the severity and the type of infection, the antibiotic may be given by mouth or by injection, or may be applied topically. Severe infections of the brain are usually treated with intravenous antibiotics. Sometimes, multiple antibiotics are used in case there is resistance to one antibiotic.

In 2018, the global Infectious Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Infectious Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Diseases development in United States, Europe and China.

The key players covered in this study

  • F. Hoffmann-La Roche
  • Gilead Sciences
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Pfizer
  • AbbVie
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Bristol-Myers Squibb
  • Chimerix Pharmaceuticals
  • Cubist
  • Eli Lilly
  • Isis Pharmaceuticals
  • Mitsubishi Tanabe Pharma
  • Novartis
  • Sanofi
  • Vertex

Market segment by Type, the product can be split into

  • Antibacterial drugs
  • Antiviral drugs
  • Antifungal drugs
  • Antiparasitic drugs

Market segment by Application, split into

  • Acquired Immune Deficiency Syndrome
  • Hepatitis B
  • Hepatitis C
  • Human Papillomavirus
  • Hospital acquired Methicillin-resistant Staphylococcus aureus infection
  • Chlamydia trachomatis and Neisseria Gonorrhea

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Infectious Diseases status, future forecast, growth opportunity, key market and key players.
  • To present the Infectious Diseases development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Infectious Diseases are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Infectious Diseases Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Antibacterial drugs
    • 1.4.3 Antiviral drugs
    • 1.4.4 Antifungal drugs
    • 1.4.5 Antiparasitic drugs
  • 1.5 Market by Application
    • 1.5.1 Global Infectious Diseases Market Share by Application (2014-2025)
    • 1.5.2 Acquired Immune Deficiency Syndrome
    • 1.5.3 Hepatitis B
    • 1.5.4 Hepatitis C
    • 1.5.5 Human Papillomavirus
    • 1.5.6 Hospital acquired Methicillin-resistant Staphylococcus aureus infection
    • 1.5.7 Chlamydia trachomatis and Neisseria Gonorrhea
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Infectious Diseases Market Size
  • 2.2 Infectious Diseases Growth Trends by Regions
    • 2.2.1 Infectious Diseases Market Size by Regions (2014-2025)
    • 2.2.2 Infectious Diseases Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Opportunities

3 Market Share by Key Players

  • 3.1 Infectious Diseases Market Size by Manufacturers
    • 3.1.1 Global Infectious Diseases Revenue by Manufacturers (2014-2019)
    • 3.1.2 Global Infectious Diseases Revenue Market Share by Manufacturers (2014-2019)
    • 3.1.3 Global Infectious Diseases Market Concentration Ratio (CR5 and HHI)
  • 3.2 Infectious Diseases Key Players Head office and Area Served
  • 3.3 Key Players Infectious Diseases Product/Solution/Service
  • 3.4 Date of Enter into Infectious Diseases Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Infectious Diseases Market Size by Type (2014-2019)
  • 4.2 Global Infectious Diseases Market Size by Application (2014-2019)

5 United States

  • 5.1 United States Infectious Diseases Market Size (2014-2019)
  • 5.2 Infectious Diseases Key Players in United States
  • 5.3 United States Infectious Diseases Market Size by Type
  • 5.4 United States Infectious Diseases Market Size by Application

6 Europe

  • 6.1 Europe Infectious Diseases Market Size (2014-2019)
  • 6.2 Infectious Diseases Key Players in Europe
  • 6.3 Europe Infectious Diseases Market Size by Type
  • 6.4 Europe Infectious Diseases Market Size by Application

7 China

  • 7.1 China Infectious Diseases Market Size (2014-2019)
  • 7.2 Infectious Diseases Key Players in China
  • 7.3 China Infectious Diseases Market Size by Type
  • 7.4 China Infectious Diseases Market Size by Application

8 Japan

  • 8.1 Japan Infectious Diseases Market Size (2014-2019)
  • 8.2 Infectious Diseases Key Players in Japan
  • 8.3 Japan Infectious Diseases Market Size by Type
  • 8.4 Japan Infectious Diseases Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Infectious Diseases Market Size (2014-2019)
  • 9.2 Infectious Diseases Key Players in Southeast Asia
  • 9.3 Southeast Asia Infectious Diseases Market Size by Type
  • 9.4 Southeast Asia Infectious Diseases Market Size by Application

10 India

  • 10.1 India Infectious Diseases Market Size (2014-2019)
  • 10.2 Infectious Diseases Key Players in India
  • 10.3 India Infectious Diseases Market Size by Type
  • 10.4 India Infectious Diseases Market Size by Application

11 Central & South America

  • 11.1 Central & South America Infectious Diseases Market Size (2014-2019)
  • 11.2 Infectious Diseases Key Players in Central & South America
  • 11.3 Central & South America Infectious Diseases Market Size by Type
  • 11.4 Central & South America Infectious Diseases Market Size by Application

12 International Players Profiles

  • 12.1 F. Hoffmann-La Roche
    • 12.1.1 F. Hoffmann-La Roche Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Infectious Diseases Introduction
    • 12.1.4 F. Hoffmann-La Roche Revenue in Infectious Diseases Business (2014-2019)
    • 12.1.5 F. Hoffmann-La Roche Recent Development
  • 12.2 Gilead Sciences
    • 12.2.1 Gilead Sciences Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Infectious Diseases Introduction
    • 12.2.4 Gilead Sciences Revenue in Infectious Diseases Business (2014-2019)
    • 12.2.5 Gilead Sciences Recent Development
  • 12.3 GlaxoSmithKline
    • 12.3.1 GlaxoSmithKline Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Infectious Diseases Introduction
    • 12.3.4 GlaxoSmithKline Revenue in Infectious Diseases Business (2014-2019)
    • 12.3.5 GlaxoSmithKline Recent Development
  • 12.4 Johnson & Johnson
    • 12.4.1 Johnson & Johnson Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Infectious Diseases Introduction
    • 12.4.4 Johnson & Johnson Revenue in Infectious Diseases Business (2014-2019)
    • 12.4.5 Johnson & Johnson Recent Development
  • 12.5 Merck
    • 12.5.1 Merck Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Infectious Diseases Introduction
    • 12.5.4 Merck Revenue in Infectious Diseases Business (2014-2019)
    • 12.5.5 Merck Recent Development
  • 12.6 Pfizer
    • 12.6.1 Pfizer Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Infectious Diseases Introduction
    • 12.6.4 Pfizer Revenue in Infectious Diseases Business (2014-2019)
    • 12.6.5 Pfizer Recent Development
  • 12.7 AbbVie
    • 12.7.1 AbbVie Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Infectious Diseases Introduction
    • 12.7.4 AbbVie Revenue in Infectious Diseases Business (2014-2019)
    • 12.7.5 AbbVie Recent Development
  • 12.8 Astellas Pharma
    • 12.8.1 Astellas Pharma Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Infectious Diseases Introduction
    • 12.8.4 Astellas Pharma Revenue in Infectious Diseases Business (2014-2019)
    • 12.8.5 Astellas Pharma Recent Development
  • 12.9 AstraZeneca
    • 12.9.1 AstraZeneca Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Infectious Diseases Introduction
    • 12.9.4 AstraZeneca Revenue in Infectious Diseases Business (2014-2019)
    • 12.9.5 AstraZeneca Recent Development
  • 12.10 Bayer
    • 12.10.1 Bayer Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Infectious Diseases Introduction
    • 12.10.4 Bayer Revenue in Infectious Diseases Business (2014-2019)
    • 12.10.5 Bayer Recent Development
  • 12.11 Bristol-Myers Squibb
  • 12.12 Chimerix Pharmaceuticals
  • 12.13 Cubist
  • 12.14 Eli Lilly
  • 12.15 Isis Pharmaceuticals
  • 12.16 Mitsubishi Tanabe Pharma
  • 12.17 Novartis
  • 12.18 Sanofi
  • 12.19 Vertex

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Regions
  • 13.2 United States
  • 13.3 Europe
  • 13.4 China
  • 13.5 Japan
  • 13.6 Southeast Asia
  • 13.7 India
  • 13.8 Central & South America
  • 13.9 Market Size Forecast by Product (2019-2025)
  • 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details

List of Tables and Figures

  • Table Infectious Diseases Key Market Segments
  • Table Key Players Infectious Diseases Covered
  • Table Global Infectious Diseases Market Size Growth Rate by Type 2014-2025 (Million US$)
  • Figure Global Infectious Diseases Market Size Market Share by Type 2014-2025
  • Figure Antibacterial drugs Figures
  • Table Key Players of Antibacterial drugs
  • Figure Antiviral drugs Figures
  • Table Key Players of Antiviral drugs
  • Figure Antifungal drugs Figures
  • Table Key Players of Antifungal drugs
  • Figure Antiparasitic drugs Figures
  • Table Key Players of Antiparasitic drugs
  • Table Global Infectious Diseases Market Size Growth by Application 2014-2025 (Million US$)
  • Figure Acquired Immune Deficiency Syndrome Case Studies
  • Figure Hepatitis B Case Studies
  • Figure Hepatitis C Case Studies
  • Figure Human Papillomavirus Case Studies
  • Figure Hospital acquired Methicillin-resistant Staphylococcus aureus infection Case Studies
  • Figure Chlamydia trachomatis and Neisseria Gonorrhea Case Studies
  • Figure Infectious Diseases Report Years Considered
  • Table Global Infectious Diseases Market Size 2014-2025 (Million US$)
  • Figure Global Infectious Diseases Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Infectious Diseases Market Size by Regions 2014-2025 (Million US$)
  • Table Global Infectious Diseases Market Size by Regions 2014-2019 (Million US$)
  • Table Global Infectious Diseases Market Share by Regions 2014-2019
  • Figure Global Infectious Diseases Market Share by Regions 2014-2019
  • Figure Global Infectious Diseases Market Share by Regions 2019
  • Table Market Top Trends
  • Table Global Infectious Diseases Revenue by Manufacturers (2014-2019) (Million US$)
  • Table Global Infectious Diseases Market Share by Manufacturers (2014-2019)
  • Figure Global Infectious Diseases Market Share by Manufacturers in 2018
  • Table Global Infectious Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Infectious Diseases Product/Solution/Service
  • Table Date of Enter into Infectious Diseases Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Infectious Diseases Market Size by Type (2014-2019) (Million US$)
  • Table Global Infectious Diseases Market Size Share by Type (2014-2019)
  • Figure Global Infectious Diseases Market Size Market Share by Type (2014-2019)
  • Table Global Infectious Diseases Market Size by Application (2014-2019) (Million US$)
  • Table Global Infectious Diseases Market Size Share by Application (2014-2019)
  • Figure Global Infectious Diseases Market Size Market Share by Application (2014-2019)
  • Figure Global Infectious Diseases Revenue Market Share by Application in 2018
  • Figure United States Infectious Diseases Market Size 2014-2019 (Million US$)
  • Table United States Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
  • Table United States Key Players Infectious Diseases Market Share (2018-2019)
  • Table United States Infectious Diseases Market Size by Type (2014-2019) (Million US$)
  • Table United States Infectious Diseases Market Share by Type (2014-2019)
  • Table United States Infectious Diseases Market Size by Application (2014-2019) (Million US$)
  • Table United States Infectious Diseases Market Share by Application (2014-2019)
  • Figure Europe Infectious Diseases Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Infectious Diseases Market Share (2018-2019)
  • Table Europe Infectious Diseases Market Size by Type (2014-2019) (Million US$)
  • Table Europe Infectious Diseases Market Share by Type (2014-2019)
  • Table Europe Infectious Diseases Market Size by Application (2014-2019) (Million US$)
  • Table Europe Infectious Diseases Market Share by Application (2014-2019)
  • Figure China Infectious Diseases Market Size 2014-2019 (Million US$)
  • Table China Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
  • Table China Key Players Infectious Diseases Market Share (2018-2019)
  • Table China Infectious Diseases Market Size by Type (2014-20189) (Million US$)
  • Table China Infectious Diseases Market Share by Type (2014-2019)
  • Table China Infectious Diseases Market Size by Application (2014-2019) (Million US$)
  • Table China Infectious Diseases Market Share by Application (2014-2019)
  • Figure Japan Infectious Diseases Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Infectious Diseases Market Share (2018-2019)
  • Table Japan Infectious Diseases Market Size by Type (2014-2019) (Million US$)
  • Table Japan Infectious Diseases Market Share by Type (2014-2019)
  • Table Japan Infectious Diseases Market Size by Application (2014-2019) (Million US$)
  • Table Japan Infectious Diseases Market Share by Application (2014-2019)
  • Figure Southeast Asia Infectious Diseases Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Infectious Diseases Market Share (2018-2019)
  • Table Southeast Asia Infectious Diseases Market Size by Type (2014-2019) (Million US$)
  • Table Southeast Asia Infectious Diseases Market Share by Type (2014-2019)
  • Table Southeast Asia Infectious Diseases Market Size by Application (2014-2019) (Million US$)
  • Table Southeast Asia Infectious Diseases Market Share by Application (2014-2019)
  • Figure India Infectious Diseases Market Size 2014-2019 (Million US$)
  • Table India Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
  • Table India Key Players Infectious Diseases Market Share (2018-2019)
  • Table India Infectious Diseases Market Size by Type (2014-2019) (Million US$)
  • Table India Infectious Diseases Market Share by Type (2014-2019)
  • Table India Infectious Diseases Market Size by Application (2014-2019) (Million US$)
  • Table India Infectious Diseases Market Share by Application (2014-2019)
  • Figure Central & South America Infectious Diseases Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Infectious Diseases Market Share (2018-2019)
  • Table Central & South America Infectious Diseases Market Size by Type (2014-2019) (Million US$)
  • Table Central & South America Infectious Diseases Market Share by Type (2014-2019)
  • Table Central & South America Infectious Diseases Market Size by Application (2014-2019) (Million US$)
  • Table Central & South America Infectious Diseases Market Share by Application (2014-2019)
  • Table F. Hoffmann-La Roche Company Details
  • Table F. Hoffmann-La Roche Revenue in Infectious Diseases Business (2014-2019) (Million US$)
  • Figure F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases Business (2014-2019)
  • Table F. Hoffmann-La Roche Recent Development
  • Table Gilead Sciences Company Details
  • Table Gilead Sciences Revenue in Infectious Diseases Business (2014-2019)(Million US$)
  • Figure Gilead Sciences Revenue Growth Rate in Infectious Diseases Business (2014-2019)
  • Table Gilead Sciences Recent Development
  • Table GlaxoSmithKline Company Details
  • Table GlaxoSmithKline Revenue in Infectious Diseases Business (2014-2019)(Million US$)
  • Figure GlaxoSmithKline Revenue Growth Rate in Infectious Diseases Business (2014-2019)
  • Table GlaxoSmithKline Recent Development
  • Table Johnson & Johnson Company Details
  • Table Johnson & Johnson Revenue in Infectious Diseases Business (2014-2019)(Million US$)
  • Figure Johnson & Johnson Revenue Growth Rate in Infectious Diseases Business (2014-2019)
  • Table Johnson & Johnson Recent Development
  • Table Merck Company Details
  • Table Merck Revenue in Infectious Diseases Business (2014-2019)(Million US$)
  • Figure Merck Revenue Growth Rate in Infectious Diseases Business (2014-2019)
  • Table Merck Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Revenue in Infectious Diseases Business (2014-2019)(Million US$)
  • Figure Pfizer Revenue Growth Rate in Infectious Diseases Business (2014-2019)
  • Table Pfizer Recent Development
  • Table AbbVie Company Details
  • Table AbbVie Revenue in Infectious Diseases Business (2014-2019)(Million US$)
  • Figure AbbVie Revenue Growth Rate in Infectious Diseases Business (2014-2019)
  • Table AbbVie Recent Development
  • Table Astellas Pharma Company Details
  • Table Astellas Pharma Revenue in Infectious Diseases Business (2014-2019)(Million US$)
  • Figure Astellas Pharma Revenue Growth Rate in Infectious Diseases Business (2014-2019)
  • Table Astellas Pharma Recent Development
  • Table AstraZeneca Company Details
  • Table AstraZeneca Revenue in Infectious Diseases Business (2014-2019)(Million US$)
  • Figure AstraZeneca Revenue Growth Rate in Infectious Diseases Business (2014-2019)
  • Table AstraZeneca Recent Development
  • Table Bayer Company Details
  • Table Bayer Revenue in Infectious Diseases Business (2014-2019)(Million US$)
  • Figure Bayer Revenue Growth Rate in Infectious Diseases Business (2014-2019)
  • Table Bayer Recent Development
  • Table Bristol-Myers Squibb Company Details
  • Table Chimerix Pharmaceuticals Company Details
  • Table Cubist Company Details
  • Table Eli Lilly Company Details
  • Table Isis Pharmaceuticals Company Details
  • Table Mitsubishi Tanabe Pharma Company Details
  • Table Novartis Company Details
  • Table Sanofi Company Details
  • Table Vertex Company Details
  • Table Global Infectious Diseases Market Size by Regions (Million US$) 2019-2025
  • Figure Global Infectious Diseases Market Size Share by Regions (2019-2025)
  • Figure Global Infectious Diseases Market Size Share by Regions in 2025
  • Figure United States Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
  • Figure China Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
  • Figure India Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
  • Table Global Infectious Diseases Market Size by Product (2019-2025) (Million US$)
  • Figure Global Infectious Diseases Market Size by Product (2019-2025)
  • Figure Global Infectious Diseases Market Size by Product in 2025
  • Table Global Infectious Diseases Market Size by Application (2019-2025) (Million US$)
  • Figure Global Infectious Diseases Market Size by Application (2019-2025)
  • Figure Global Infectious Diseases Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top